中國的眼科市場(2024年):2023年～2029年的各地區分析

本報告提供中國的眼科市場相關調查，提供市場概要，以及中國的人口和經濟狀況整體性概要，重要的策略性問題，疾病的盛行率，重要的未來趨勢，及加入此市場的主要企業32公司的企業簡介等。

目錄

• 中國概況，包括人口統計、中國經濟以及中國衛生基礎設施分析
• 疾病流行數據
• 眼科醫師、外科醫師、驗光師、醫院、診所
• 手術治療
• 手術器械與技術的使用
• 眼科藥物治療方案
• 五年市場表現預測
• 在中國經營眼科產品的公司名單
• 32 位參賽者的簡介

What's New:

The new "2024 China Ophthalmic Market Report" features expanded analysis of regulations and a snapshot of the Chinese government's Volume-Based Procurement strategies designed to reduce prices and improve access to care. All product category forecasts have been updated through 2029 and examine revenue in both yuan and dollars.

The new report provides updates on Chinese companies and private hospital chains, thoroughly examines ophthalmic product candidates at Chinese pharmaceutical companies, and provides an updated listing of companies selling and distributing ophthalmic products in China.

The "2024 China Ophthalmic Market Report" covers all aspects of China's ophthalmic market, providing a comprehensive overview of the Chinese population and economic conditions, discussing key strategic issues, studying disease prevalence, and analyzing surgical and therapeutic approaches, including both commercialized and pipeline products. The report analyzes unit demand and revenue, and forecasts future performance over the next five years. Competitor share is analyzed by product category and 32 competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

Contents:

The report offers an in-depth examination of the ophthalmic market in China, discussing important trends and key factors for future success. The report looks at the market's evolution and forecasts growth over the next five years for 10 submarkets: cataract, refractive, cornea, glaucoma, retina, dry eye, diagnostic equipment, multi-specialty lasers, surgical instruments, and single-use surgical devices.

The following information is also included:

• Overview of China, including an analysis of population demographics, the Chinese economy, and China's health care infrastructure.
• Disease prevalence data.
• Ophthalmologists, surgeons, optometrists, hospitals, and clinics.
• Surgical treatments.
• Surgical instrument and technology usage.
• Ophthalmic pharmaceutical treatment regimens.
• Five-year forecasts for market performance.
• List of companies with ophthalmic products in China.
• 32 competitor profiles.

Author Profile:

Peter Downs

Peter Downs has more than 30 years of experience as a business and medical journalist and investigative reporter. He has written for a variety of medical industry publications, including the Medical Business Journal, CBS HealthWatch, and Oncology News International.

Prior to joining Market Scope in 2015 and turning his attention to ophthalmology, Peter analyzed markets for organ and tissue transplantation. Since joining Market Scope, he has traveled to several markets outside the US, including China, Europe, and India, to study ophthalmology at the local level.

In addition to his research and writing efforts on the ophthalmic market, he is also a contributor to Ophthalmic Market Perspectives, the firm's monthly industry newsletter.